| # | Title | Journal | Year | Citations |
|---|
| 1 | Photodynamic Therapy | Journal of the National Cancer Institute | 1998 | 4,721 |
| 2 | Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) | Autophagy | 2016 | 4,701 |
| 3 | Photodynamic therapy of cancer: An update | Ca-A Cancer Journal for Clinicians | 2011 | 3,902 |
| 4 | Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries | Lancet, The | 2018 | 3,228 |
| 5 | ABySS: A parallel assembler for short read sequence data | Genome Research | 2009 | 3,134 |
| 6 | Guidelines for the use and interpretation of assays for monitoring autophagy | Autophagy | 2012 | 3,122 |
| 7 | National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report | Biology of Blood and Marrow Transplantation | 2015 | 2,636 |
| 8 | AGREE II: advancing guideline development, reporting and evaluation in health care | Cmaj | 2010 | 2,389 |
| 9 | Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer | New England Journal of Medicine | 2016 | 1,860 |
| 10 | Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer | Journal of the National Cancer Institute | 2009 | 1,844 |
| 11 | Generation of a functional mammary gland from a single stem cell | Nature | 2006 | 1,824 |
| 12 | The clonal and mutational evolution spectrum of primary triple-negative breast cancers | Nature | 2012 | 1,778 |
| 13 | Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial | Lancet, The | 2017 | 1,728 |
| 14 | Metastatic Behavior of Breast Cancer Subtypes | Journal of Clinical Oncology | 2010 | 1,718 |
| 15 | The NIH Roadmap Epigenomics Mapping Consortium | Nature Biotechnology | 2010 | 1,705 |
| 16 | Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women with Breast Cancer | New England Journal of Medicine | 1997 | 1,657 |
| 17 | Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer | New England Journal of Medicine | 2017 | 1,588 |
| 18 | Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma | Genome Research | 2012 | 1,582 |
| 19 | Conserved role of intragenic DNA methylation in regulating alternative promoters | Nature | 2010 | 1,568 |
| 20 | Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin | Nature Genetics | 2010 | 1,504 |
| 21 | Volumetric modulated arc therapy: IMRT in a single gantry arc | Medical Physics | 2008 | 1,471 |
| 22 | ARID1AMutations in Endometriosis-Associated Ovarian Carcinomas | New England Journal of Medicine | 2010 | 1,460 |
| 23 | Integrated genomic characterization of oesophageal carcinoma | Nature | 2017 | 1,448 |
| 24 | Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 | Autophagy | 2021 | 1,430 |
| 25 | Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma | Nature | 2011 | 1,428 |
| 26 | Purification and unique properties of mammary epithelial stem cells | Nature | 2006 | 1,404 |
| 27 | Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma | Nature | 2010 | 1,402 |
| 28 | Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial | Lancet, The | 2002 | 1,340 |
| 29 | Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome | Clinical Cancer Research | 2008 | 1,312 |
| 30 | Oncogenically active MYD88 mutations in human lymphoma | Nature | 2011 | 1,292 |
| 31 | Evolutionary and Biomedical Insights from the Rhesus Macaque Genome | Science | 2007 | 1,283 |
| 32 | Enhancing the scoping study methodology: a large, inter-professional team’s experience with Arksey and O’Malley’s framework | BMC Medical Research Methodology | 2013 | 1,212 |
| 33 | The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP | Blood | 2007 | 1,193 |
| 34 | Constructing Experimental Designs for Discrete-Choice Experiments: Report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force | Value in Health | 2013 | 1,169 |
| 35 | A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse | British Journal of Cancer | 2000 | 1,154 |
| 36 | Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma | Science | 2014 | 1,147 |
| 37 | Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma | New England Journal of Medicine | 2010 | 1,141 |
| 38 | Association analysis identifies 65 new breast cancer risk loci | Nature | 2017 | 1,099 |
| 39 | Breast Cancer Subtypes and the Risk of Local and Regional Relapse | Journal of Clinical Oncology | 2010 | 1,072 |
| 40 | Cancer survival in five continents: a worldwide population-based study (CONCORD) | Lancet Oncology, The | 2008 | 1,059 |
| 41 | Cancer stem cells: an evolving concept | Nature Reviews Cancer | 2012 | 1,055 |
| 42 | Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype | Clinical Cancer Research | 2008 | 1,040 |
| 43 | Complementation Cloning of NEMO, a Component of the IκB Kinase Complex Essential for NF-κB Activation | Cell | 1998 | 1,030 |
| 44 | Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study | Lancet Oncology, The | 2011 | 1,028 |
| 45 | The Atlantic salmon genome provides insights into rediploidization | Nature | 2016 | 1,021 |
| 46 | The Genome of the Sea Urchin Strongylocentrotus purpuratus | Science | 2006 | 1,018 |
| 47 | Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase | Proceedings of the National Academy of Sciences of the United States of America | 1998 | 1,012 |
| 48 | Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution | Nature | 2009 | 984 |
| 49 | Telomeres and Aging | Physiological Reviews | 2008 | 980 |
| 50 | Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial | Lancet Oncology, The | 2017 | 975 |
